(1)
Hellström, V. C.; Enström, Y.; von Zur-Mühlen, B.; Hagberg, H.; Laurell, A.; Nyberg, F.; Bäckman, L.; Opelz, G.; Döhler, B.; Holmberg, L. Malignancies in Transplanted Patients: Multidisciplinary Evaluation and Switch to MTOR Inhibitors After Kidney Transplantation – Experiences from a Prospective, Clinical, Observational Study. AO 2016, 55, 774-781.